News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
213 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26337)
Month
January (4451)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (375)
2 (349)
3 (253)
4 (26)
5 (31)
6 (262)
7 (275)
8 (242)
9 (213)
10 (132)
11 (8)
12 (10)
13 (190)
14 (224)
15 (168)
16 (184)
17 (128)
18 (4)
19 (3)
20 (85)
21 (267)
22 (199)
23 (205)
24 (113)
25 (10)
26 (5)
27 (194)
28 (228)
29 (213)
30 (209)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Biotech Bay
Pulse Biosciences, Inc. Announces the Closing of Its Rights Offering
Pulse Biosciences, Inc., a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ technology, announced the closing of its rights offering and the final results thereof.
June 9, 2022
·
5 min read
Healthcare Is Personal: GE Healthcare’s Total Molecular Imaging Solutions Enable Precision Health & Theranostics for Personalized Prostate Cancer Care
GE Healthcare is proud to provide cutting-edge molecular imaging solutions that enable and increase access to precision health and theranostics to help improve patient outcomes across care areas, including prostate cancer – the most prevalent cancer in men and the third most prevalent cancer overalli.
June 9, 2022
·
11 min read
Pharm Country
Ocugen, Inc. to Present at BIO International Convention 2022
Ocugen, Inc. announced that Michael Shine, Ocugen’s Senior Vice President, Commercial, will present at the 2022 BIO International Convention being held in San Diego, California, from June 13-16, 2022.
June 9, 2022
·
2 min read
Biotech Beach
NEURELIS STUDY PUBLISHED IN EPILEPSIA, A WORLD-CLASS JOURNAL DEDICATED TO EPILEPSY
Neurelis, Inc., announced the publication of a study recently available online in the peer-reviewed, scientific journal Epilepsia.
June 9, 2022
·
6 min read
Immune Checkpoint Inhibitors Driving Combination Cancer Immunotherapy Market
Recently, immune checkpoint inhibitors have emerged as one of the promising class of immunotherapy approaches in the management of cancer.
June 9, 2022
·
4 min read
BioMidwest
Dyadic to Participate in Three Upcoming Industry Events in June 2022
Dyadic International, Inc. announced that its management and representatives will participate in the following three upcoming industry events in June 2022:
June 9, 2022
·
3 min read
Drug Development
Sermonix to Host Virtual Clinical Update on its ELAINE Phase 2 Clinical ProgramsKey Opinion Leader (KOL) webinar scheduled for Wednesday, June 15, at 10:00 a.m. EDT
Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated metastatic breast and gynecological cancers, today announced that it will host a virtual update on its ELAINE Phase 2 clinical programs on Wednesday, June 15 at 10:00 a.m. EDT.
June 9, 2022
·
5 min read
Business
Tempus Announces Sequencing Collaboration With Lilly to Expand Access to Genomic Testing
Tempus, a leader in artificial intelligence and precision medicine, today announced a new collaboration sponsored by Eli Lilly and Company designed to provide broader access to genomic testing to patients with advanced/metastatic non-small cell lung cancer (NSCLC).
June 9, 2022
·
2 min read
BioCapital
Indivior Announces Seven Abstracts Accepted for Presentation at the 84th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD)
Indivior PLC (LON: INDV) today announced the acceptance of seven abstracts for presentation at the 84th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD) taking place June 11-15, 2022 in Minneapolis, MN.
June 9, 2022
·
9 min read
Anesthesia CO2 Absorbent Market Growth 2022-2030: Increasing Number of People Suffering from Chronic Diseases is Driving Industry Revenue
Cardiothoracic, orthopedic, vascular, and neurological diseases or disorders usually necessitate surgical treatment.
June 9, 2022
·
7 min read
Previous
21 of 22
Next